Ebola vaccine built on same technology as Covid-19 jab from J&J shows long-lasting success

Just weeks after a J&J candidate failed its first trial in an effort to build a vaccine against HIV, that same vaccine technology scored the company a victory in the fight against a virus that has emerged yet again, and threatens to cause havoc in Africa if left unchecked alongside Covid-19.